QUANTITATIVE NEUROLOGIC AND NEUROBEHAVIORAL TESTING OF PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1

被引:29
|
作者
FRANZBLAU, A
LETZ, R
HERSHMAN, D
MASON, P
WALLACE, JI
BEKESI, JG
机构
[1] CUNY MT SINAI SCH MED,DEPT COMMUNITY MED,NEW YORK,NY 10029
[2] CUNY MT SINAI SCH MED,DEPT NUCL ENERGY,NEW YORK,NY 10029
关键词
D O I
10.1001/archneur.1991.00530150031013
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Assessment of neurobehavioral and peripheral neurologic performance among homosexual men was made on two occasions, using a computer-administered neurobehavioral instrument and quantitative vibration threshold testing, respectively. Persons studied included high-risk human immunodeficiency virus (HIV)-negative men (n = 13), asymptomatic HIV-positive men (n = 30), and patients with acquired immunodeficiency syndrome (AIDS)-related complex or AIDS (n = 17). In addition, subjects were characterized immunologically at the time of neurologic and neuropsychologic assessment via determination of circulating lymphocyte counts (total lymphocytes, helper T cells, suppressor T cells, total T cells, activated T cells) and markers of HIV type 1 (HIV-1) infection. At the first cycle of testing, the results of asymptomatic HIV-positive men were indistinguishable from those of HIV-negative men, while persons with AIDS-related complex or AIDS tended to have lower mean performance. These differences did not achieve statistical significance on any single test, but the group with AIDS-related complex or AIDS had the worst mean performance on 12 of 13 individual performance tests. Thirty-seven men underwent repeated testing after a mean interval of approximately 4.5 months. There was little change in mean neurobehavioral performance and vibratory thresholds among all three groups. Measures of neurobehavioral performance and vibrotactile thresholds were not correlated with measures of immunological status. These results are consistent with the concept that asymptomatic infection with HIV-1 does not imply the presence of measurable or significant neurologic or neurobehavioral impairment.
引用
收藏
页码:263 / 268
页数:6
相关论文
共 50 条
  • [31] DETECTION OF PROVIRAL SEQUENCES IN SALIVA OF PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    GOTO, Y
    YEH, CK
    NOTKINS, AL
    PRABHAKAR, BS
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1991, 7 (03) : 343 - 347
  • [32] PERTUSSIS TOXIN INHIBITS INDUCTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN INFECTED MONOCYTES
    CHOWDHURY, IH
    KOYANAGI, Y
    HAZEKI, O
    UI, M
    YAMAMOTO, N
    VIROLOGY, 1994, 203 (02) : 378 - 383
  • [33] SOLUBLE CD23 IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTED PATIENTS
    HOBER, D
    AJANA, F
    BONIFACE, M
    ESTRADA, R
    LOBERT, PE
    SARTIAUX, C
    MOUTON, Y
    WATTRE, P
    MANIEZMONTREUIL, M
    MICROBIOLOGY AND IMMUNOLOGY, 1993, 37 (05) : 383 - 390
  • [34] CONSEQUENCES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SUPERINFECTION OF CHRONICALLY INFECTED-CELLS
    KIM, JH
    MOSCA, JD
    VAHEY, MT
    MCLINDEN, RJ
    BURKE, DS
    REDFIELD, RR
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (09) : 875 - 882
  • [35] NONORGAN-SPECIFIC AUTOANTIBODIES IN INDIVIDUALS INFECTED WITH TYPE-1 HUMAN-IMMUNODEFICIENCY-VIRUS
    GENTRIC, A
    BLASCHEK, M
    JULIEN, C
    JOUQUAN, J
    PENNEC, Y
    BERTHELOT, JM
    MOTTIER, D
    CASBURNBUDD, R
    YOUINOU, P
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1991, 59 (03): : 487 - 494
  • [36] THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIF GENE - THE ROAD FROM AN ACCESSORY TO AN ESSENTIAL ROLE IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION
    VOLSKY, DJ
    POTASH, MJ
    SIMM, M
    SOVA, P
    MA, XY
    CHAO, W
    SHAHABUDDIN, M
    TRANSACTING FUNCTIONS OF HUMAN RETROVIRUSES, 1995, 193 : 157 - 168
  • [37] THE SPECIFICITY OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 TRANSACTIVATOR IS DIFFERENT FROM THAT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    EMERMAN, M
    GUYADER, M
    MONTAGNIER, L
    BALTIMORE, D
    MUESING, MA
    EMBO JOURNAL, 1987, 6 (12): : 3755 - 3760
  • [38] IMMUNOPRECIPITATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 GLYCOPROTEINS BY SERA POSITIVE FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    ESPEJO, RT
    URIBE, P
    JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (09) : 2107 - 2110
  • [39] EARLY INTERVENTION FOR PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS
    BRANSON, BM
    CLINICAL INFECTIOUS DISEASES, 1995, 20 : S3 - S22
  • [40] DISSEMINATED HISTOPLASMOSIS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS
    HAJJEH, RA
    CLINICAL INFECTIOUS DISEASES, 1995, 21 : S108 - S110